share_log

Assure | 8-K: Current report

Assure | 8-K: Current report

Assure | 8-K:重大事件
美股sec公告 ·  05/22 16:11
Moomoo AI 已提取核心信息
On May 22, 2024, Assure Holdings Corp., a Nevada-based company listed on the NASDAQ Capital Market under the trading symbol IONM, filed a Form 8-K with the United States Securities and Exchange Commission (SEC). The report announced a corporate update call held by Assure and Danam Health, Inc. on the same day. The presentation from the call was filed as Exhibit 99.1 and is incorporated by reference. Assure, which is classified as an emerging growth company, has also filed a registration statement on Form S-4 with the SEC on May 3, 2024, containing a prospectus and a proxy statement in connection with a proposed transaction between Assure and Danam Health Inc. The proxy statement/prospectus will be mailed to stockholders of both companies, and...Show More
On May 22, 2024, Assure Holdings Corp., a Nevada-based company listed on the NASDAQ Capital Market under the trading symbol IONM, filed a Form 8-K with the United States Securities and Exchange Commission (SEC). The report announced a corporate update call held by Assure and Danam Health, Inc. on the same day. The presentation from the call was filed as Exhibit 99.1 and is incorporated by reference. Assure, which is classified as an emerging growth company, has also filed a registration statement on Form S-4 with the SEC on May 3, 2024, containing a prospectus and a proxy statement in connection with a proposed transaction between Assure and Danam Health Inc. The proxy statement/prospectus will be mailed to stockholders of both companies, and the transaction is subject to stockholder approval and other customary closing conditions. The report includes forward-looking statements regarding the proposed transaction, including the anticipated structure, timing, and completion, as well as the expected executive officers and directors of the combined company post-merger. Assure has advised investors and securityholders to read the materials filed with the SEC once available, as they contain important information about the proposed transactions. The documents can be obtained from Assure's website or the SEC's website. The report also contains cautionary statements about potential risks and uncertainties that could affect the actual results and the timing of events related to the proposed transactions.
2024年5月22日,总部位于内华达州的在纳斯达克资本市场上市的公司Assure Holdings Corp. 向美国证券交易委员会(SEC)提交了8-K表格。该报告宣布了Assure和Danam Health, Inc.于当天举行的公司最新情况电话会议。电话会议上的演示文稿作为附录99.1提交,并以引用方式纳入。被归类为新兴成长型公司的Assure也于2024年5月3日向美国证券交易委员会提交了S-4表格的注册声明,其中包含与Assure和Danam Health Inc.之间拟议交易有关的招股说明书和委托声明。委托书/招股说明书将邮寄给两家公司的股东,该交易需获得股东批准和其他惯例成交条件...展开全部
2024年5月22日,总部位于内华达州的在纳斯达克资本市场上市的公司Assure Holdings Corp. 向美国证券交易委员会(SEC)提交了8-K表格。该报告宣布了Assure和Danam Health, Inc.于当天举行的公司最新情况电话会议。电话会议上的演示文稿作为附录99.1提交,并以引用方式纳入。被归类为新兴成长型公司的Assure也于2024年5月3日向美国证券交易委员会提交了S-4表格的注册声明,其中包含与Assure和Danam Health Inc.之间拟议交易有关的招股说明书和委托声明。委托书/招股说明书将邮寄给两家公司的股东,该交易需获得股东批准和其他惯例成交条件。该报告包括有关拟议交易的前瞻性陈述,包括预期的结构、时间和完成,以及合并后公司的预期执行官和董事。Assure建议投资者和证券持有人阅读向美国证券交易委员会提交的材料,因为这些材料包含有关拟议交易的重要信息。这些文件可以从Assure的网站或美国证券交易委员会的网站上获得。该报告还包含有关潜在风险和不确定性的警示性声明,这些风险和不确定性可能会影响与拟议交易相关的实际结果和事件发生时间。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息